Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-23

FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sovaldi (sofosbuvir) submitted by Gilead Sciences, Inc. The approval expands the approved use of the drug for treati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sovaldi (Sofosbuvir)

Snippet

SUPPL AP for SOVALDI (SOFOSBUVIR)